| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Docetaxel | CTRPv2 | pan-cancer | AAC | 0.029 | 0.6 |
| mRNA | selumetinib:JQ-1 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.021 | 0.6 |
| mRNA | Gefitinib | GDSC1000 | pan-cancer | AAC | 0.019 | 0.6 |
| mRNA | SMER-3 | CTRPv2 | pan-cancer | AAC | -0.023 | 0.6 |
| mRNA | Ko-143 | CTRPv2 | pan-cancer | AAC | -0.022 | 0.6 |
| mRNA | Imatinib | FIMM | pan-cancer | AAC | -0.11 | 0.6 |
| mRNA | AKT inhibitor VIII | GDSC1000 | pan-cancer | AAC | 0.02 | 0.6 |
| mRNA | MK 1775 | CTRPv2 | pan-cancer | AAC | -0.02 | 0.6 |
| mRNA | alvocidib | CTRPv2 | pan-cancer | AAC | -0.029 | 0.6 |
| mRNA | Vorinostat | GDSC1000 | pan-cancer | AAC | -0.018 | 0.6 |